About Covis

Founded in 2011, Covis Pharma is a private equity backed global specialty pharmaceutical company that markets therapeutic solutions in 50+ countries, for patients with life-threatening conditions and chronic illnesses.

Our purpose is to turn untapped potential into global medical therapies that improve our patients’ lives. Apollo Global Management, with approximately $600 billion AUM, is the private equity sponsor of Covis Pharma.


Click here to access our California Compliance Statement and Declaration.

15+  Brands in the current portfolio

Sold in  50+  countries

Long-term supply agreements with  10+  manufacturers ensuring supply chain security

Purpose & Values

Our Purpose

We turn untapped potential into global medical therapies that improve our patients’ lives.

Our Values

One Team

We believe in collaborative teamwork to achieve common goals


We are relentless in the pursuit of our mission to serve our patients


We embrace change, take smart risks, and learn from our mistakes


We build trust through transparency

Do the Right Thing

We put patients first by being honest and accountable in all our actions


Emanuele Pizzo

Vice President, Finance, EU and International


We partner with the world’s leading pharmaceutical companies and contract manufacturing organizations to deliver an uninterrupted supply of high-quality pharmaceuticals.

Operational Capabilities

Covis has unparalleled expertise across all functional areas with a flawless history of executing commercial onboarding, tech transferring, and launching authorized generic and line extension products.

Business Development

Covis is always evaluating products and corporate acquisition opportunities with significant resources committed from its equity sponsors for tack-on deals and larger transaction opportunities. For all partnering inquiries, please contact us.

Product Development

Covis is devoted to developing new therapeutic solutions to improve patients’ quality of life through line extensions of its existing portfolio as well as selected novel late-stage clinical programs.

Our Operating Partners

Our Business Development Partners

Our Authorized Distributors of Record



United States

Brazil and Mexico

South Africa

Skip to content